spacer
home > white papers > Risk-Based Inspection Readiness: Reducing Headaches with Advanced Preparation - The Avoca Group
WHITE PAPERS
logo_The_Avoca_.jpg

The Avoca Group

phone (609) 252-9020
web http://theavocagroup.com/
email 179 Nassau St., Suite 3A, Princeton, NJ 08542

Risk-Based Inspection Readiness: Reducing Headaches with Advanced Preparation

So often, inspections are a major source of stress in the clinical trial environment. This is especially true when processes involved in preparing for an inspection are reactive. But, it doesn’t have to be that way. Using industry-leading practices and resources enables a proactive approach to mitigate—or even eliminate—the pain points associated with preparing for inspections.

The term “risk-based approach” encompasses all activities related to risk-based quality management (RBQM). RBQM is defined as a “systematic process put in place to identify, assess, control, communicate, and review the risks associated with the clinical trial during its lifecycle.


Risk-Based Inspection Readiness: Reducing Headaches with Advanced Preparation
spacer

Member login

E-mail address:

Password:
Remember me


News and Press Releases

Merck Introduces Parteck® COAT Excipient, a Fast-Dissolving Material for Immediate Release Coating

• Designed to simplify the formulation and coating process for tablets • Optimized particle size leads to fast dissolving and increases coating process efficiency Merck has launched its Parteck® COAT excipient, a new functional material designed for immediate release film coating applications. Parteck® COAT is a particle engineered polyvinyl alcohol (PVA) with a unique particle structure that enables rapid dissolution even at low temperatures leading to an increased process efficiency.
More info >>


White Papers

Interface: Drug Delivery Devices

Phillips-Medisize

A family is packing for its annual summer trek to the cottage by the lake. Along with fishing gear, sunscreen, and life vests, the checklist also includes another kind of life saver – an autoinjector that delivers two doses of epinephrine to treat anaphylaxis, a severe and potentially lifethreatening allergic reaction.
More info >>


Industry Events

Clinical Operations in Oncology Trials West Coast

17-18 November 2020, Hilton San Francisco Airport Bayfront

Clinical Operations in Oncology Trials West Coast will be returning this April for another 2 day event full of thought-provoking presentations, discussions and roundtables. This years' conference highlights include the high-level, interactive immuno-oncology discussion panel where specialists from Shasta Bio Ventures, Abbvie and BeiGene shared their top tips on how to run successful and impactful immuno-oncology studies.
More info >>


©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement